AstraZeneca secures US approval for Saphnelo self-administration in lupus treatment

Abbott presents late-breaking clinical data on treating heart rhythm disorders

Novartis receives positive CHMP opinion for Itvisma in spinal muscular atrophy

Servier completes Day One Biopharmaceuticals acquisition

Cipla's AB-rated Ventolin HFA generic receives US FDA approval

FDA expands Sanofi and Regeneron's Dupixent approval to younger children with chronic spontaneous urticaria

WuXi Biologics gains MFDS approval for three Wuxi manufacturing sites

OrganaBio and RxMP Therapeutics partner to advance RMP-402 haemostatic drug product

Thryv Therapeutics doses first patients in Wave II clinical study for Long QT Syndrome; THRV-1268 receives FDA Fast Track Designation

WuXi Biologics receives South Korean certification for commercial manufacturing of bispecific antibody therapeutics

Labcorp launches FDA-approved companion diagnostic to identify ovarian cancer patients' KEYTRUDA eligibility

European Commission approves Ojemda as first targeted therapy for relapsed paediatric low-grade glioma

Renalytix advances kidneyintelX.Dkd scale-up with laboratory expansion and CE submission

FDA extends review timeline for Sanofi's Sarclisa subcutaneous formulation in multiple myeloma

FDA expands approval of Sanofi's Tzield for early-stage type 1 diabetes in young children